+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

Levodopa - Global Strategic Business Report - Product Thumbnail Image

Levodopa - Global Strategic Business Report

  • Report
  • July 2025
  • 377 Pages
  • Global
From
From
From
From
Episodic Ataxia Treatment Market Report 2025 - Product Thumbnail Image

Episodic Ataxia Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Lewy Body Dementia Treatment Market Report 2025 - Product Thumbnail Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-Parkinson Drugs Market Report 2025 - Product Thumbnail Image

Anti-Parkinson Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Parkinson's Disease Global Market Report 2025 - Product Thumbnail Image

Parkinson's Disease Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 382 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 898 Pages
  • Global
From
Multiple System Atrophy Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Multiple System Atrophy Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Parkinson's Disease Market Report and Forecast 2025-2034 - Product Thumbnail Image

Parkinson's Disease Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Parkinsons Disease Market - Product Thumbnail Image

Parkinsons Disease Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Dyskinesia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyskinesia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more